Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · IEX Real-Time Price · USD
2.560
-0.100 (-3.76%)
Apr 19, 2024, 3:59 PM EDT - Market closed

Alpha Tau Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Selling, General & Admin
9.2611.252.341.71.37
Research & Development
26.4220.8911.457.546.64
Operating Expenses
35.6832.1413.799.248.01
Operating Income
-35.68-32.14-13.79-9.24-8.01
Interest Expense / Income
6.54-1.61-13.470.52-0.31
Other Expense / Income
-13.083.2126.95-1.040.52
Pretax Income
-29.14-33.74-27.26-8.72-8.22
Income Tax
0.020.020.010.160.15
Net Income
-29.16-33.76-27.27-8.88-8.37
Shares Outstanding (Basic)
6964414034
Shares Outstanding (Diluted)
6964414034
Shares Change
9.20%56.74%0.64%19.10%-
EPS (Basic)
-0.42-0.53-0.67-0.22-0.25
EPS (Diluted)
-0.42-0.53-0.67-0.22-0.25
Free Cash Flow
-24.36-24.78-14.74-11.02-8.2
Free Cash Flow Per Share
-0.35-0.39-0.36-0.27-0.24
EBITDA
-21.53-34.37-39.96-8.12-8.46
Depreciation & Amortization
1.070.980.780.090.07
EBIT
-22.6-35.35-40.74-8.2-8.53
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).